Obatala Sciences, Harvard partner on human fat tissue study
New Orleans-based biotechnology firm Obatala Sciences has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro.
The licensed Harvard technology, an adipose-on-a-chip, provides a method of obtaining adult-size fat tissue cells for study in vitro and enables the testing of weight loss and cancer-targeting therapeutics without the need for testing in animals, a news release said. It provides a more accurate and dynamic model of human tissue in its diseased state compared to traditional 2-dimensional culture, the release said.